121 related articles for article (PubMed ID: 35792605)
1. MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
[TBL] [Abstract][Full Text] [Related]
2. miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness.
Liu XL; Liu WJ; Chen Q; Liu J; Yang CQ; Zhang G; Zhang SL; Guo WH; Li JB; Zhao G; Yin DC; Zhang CY
Mol Carcinog; 2021 Aug; 60(8):538-555. PubMed ID: 34062009
[TBL] [Abstract][Full Text] [Related]
3. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract][Full Text] [Related]
5. Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
Biomater Sci; 2024 Feb; 12(5):1332-1334. PubMed ID: 38362932
[TBL] [Abstract][Full Text] [Related]
6. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
7. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
8. The regulation of miR-139-5p on the biological characteristics of breast cancer cells by targeting COL11A1.
Gu SQ; Luo JH; Yao WX
Math Biosci Eng; 2019 Nov; 17(2):1428-1441. PubMed ID: 32233587
[No Abstract] [Full Text] [Related]
9. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
Wang L; Yi J; Lu LY; Zhang YY; Wang L; Hu GS; Liu YC; Ding JC; Shen HF; Zhao FQ; Huang HH; Liu W
Theranostics; 2021; 11(4):1732-1752. PubMed ID: 33408778
[TBL] [Abstract][Full Text] [Related]
12. COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.
Li A; Li J; Lin J; Zhuo W; Si J
Oncol Rep; 2017 Jan; 37(1):333-340. PubMed ID: 28004111
[TBL] [Abstract][Full Text] [Related]
13. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
14. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
18. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
[TBL] [Abstract][Full Text] [Related]
19. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer.
Nallanthighal S; Rada M; Heiserman JP; Cha J; Sage J; Zhou B; Yang W; Hu Y; Korgaonkar C; Hanos CT; Ashkavand Z; Norman K; Orsulic S; Cheon DJ
Cell Death Dis; 2020 Apr; 11(4):258. PubMed ID: 32312965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
